Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (271-280 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Journal of the American College of Cardiology|February 15, 2020
Stent-Related Adverse Events >1 Year After Percutaneous Coronary InterventionMahesh V Madhavan, Ajay J Kirtane, Björn Redfors, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
The American Journal of Cardiology|July 6, 2010
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)Ajay J Kirtane, Helen Parise, Roxana Mehran, et al.
ESC Heart Failure|February 19, 2026
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER studyDennis M McNamara, Leslie T Cooper, Matthias G Friedrich, et al.
American Heart Journal|December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT studyUsman Baber, George Dangas, David J Cohen, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
International Journal of Cardiology|May 28, 2014
Current challenges for clinical trials of cardiovascular medical devicesFaiez Zannad, Wendy Gattis Stough, Ileana L Piña, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2011
The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgeryMark A Hlatky, David Shilane, Derek B Boothroyd, et al.
Lancet (London, England)|September 1, 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran, Alexandra J Lansky, Bernhard Witzenbichler, et al.
Pageof 35

Showing results (271-280 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Journal of the American College of Cardiology|February 15, 2020
Stent-Related Adverse Events >1 Year After Percutaneous Coronary InterventionMahesh V Madhavan, Ajay J Kirtane, Björn Redfors, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
The American Journal of Cardiology|July 6, 2010
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)Ajay J Kirtane, Helen Parise, Roxana Mehran, et al.
ESC Heart Failure|February 19, 2026
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER studyDennis M McNamara, Leslie T Cooper, Matthias G Friedrich, et al.
American Heart Journal|December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT studyUsman Baber, George Dangas, David J Cohen, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
International Journal of Cardiology|May 28, 2014
Current challenges for clinical trials of cardiovascular medical devicesFaiez Zannad, Wendy Gattis Stough, Ileana L Piña, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2011
The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgeryMark A Hlatky, David Shilane, Derek B Boothroyd, et al.
Lancet (London, England)|September 1, 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran, Alexandra J Lansky, Bernhard Witzenbichler, et al.
Pageof 35